Literature DB >> 16720467

Magnetic resonance imaging changes in Fabry disease.

Lionel Ginsberg1, Renzo Manara, Alan R Valentine, Brian Kendall, Alessandro P Burlina.   

Abstract

UNLABELLED: Recognized magnetic resonance imaging (MRI) abnormalities in the brains of patients with Fabry disease include the consequences of infarction and haemorrhage, non-specific white and grey matter lesions, vascular anomalies, in particular dolicho-ectasia, and a characteristic appearance of the posterior thalamus. A preliminary analysis of MRI findings in patients registered in FOS, the Fabry Outcome Survey, indicates that most patients had abnormal scans (25/47). The commonest abnormality, in males and females, was the presence of cerebral white matter lesions, the number of which increased with patient age.
CONCLUSION: MRI is a valuable resource for assessing the CNS complications of Fabry disease, and their response to time and treatment.

Entities:  

Mesh:

Year:  2006        PMID: 16720467     DOI: 10.1080/08035320600618908

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  11 in total

1.  Homocysteine and erythrocyte sedimentation rate correlate with cerebrovascular disease in fabry disease.

Authors:  R Cheung; D O Sillence; M C Tchan
Journal:  JIMD Rep       Date:  2012-02-01

2.  Lysosomal delivery of therapeutic enzymes in cell models of Fabry disease.

Authors:  D Marchesan; T M Cox; P B Deegan
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

3.  Detecting the effects of Fabry disease in the adult human brain with diffusion tensor imaging and fast bound-pool fraction imaging.

Authors:  Hunter R Underhill; Katie Golden-Grant; Lauren T Garrett; Stefanie Uhrich; Brandon A Zielinski; C Ronald Scott
Journal:  J Magn Reson Imaging       Date:  2015-05-27       Impact factor: 4.813

Review 4.  Pulvinar Sign, Stroke and Their Relationship with Fabry Disease: A Systematic Review and Metanalysis.

Authors:  Juan Fernando Ortíz; María Belén Solís; Syed Saad Ali; Mahika Khurana; Juan Andrés Moncayo; Nishel Yogesh Kothari; Mateo Alzamora; Ahmed Eissa-Garces; Ghanshyam Patel; Gustavo Andrés Monteros; Meghdeep Sen; Jonathan Quiñonez
Journal:  Neurol Int       Date:  2022-06-01

5.  Nervous system and Fabry disease, from symptoms to diagnosis: damage evaluation and follow-up in adult patients, enzyme replacement, and support therapy.

Authors:  Alessandro Salviati; Alessandro P Burlina; Walter Borsini
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

6.  The pulvinar sign: frequency and clinical correlations in Fabry disease.

Authors:  Alessandro P Burlina; Renzo Manara; Catherine Caillaud; Jean-Pierre Laissy; Mariasavina Severino; Isabelle Klein; Alberto Burlina; Olivier Lidove
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

7.  Voxel based analyses of diffusion tensor imaging in Fabry disease.

Authors:  J Albrecht; P R Dellani; M J Müller; I Schermuly; M Beck; P Stoeter; A Gerhard; A Fellgiebel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

Review 8.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

9.  Brain involvement in Alström syndrome.

Authors:  Valentina Citton; Angela Favaro; Vera Bettini; Joseph Gabrieli; Gabriella Milan; Nella Augusta Greggio; Jan D Marshall; Jürgen K Naggert; Renzo Manara; Pietro Maffei
Journal:  Orphanet J Rare Dis       Date:  2013-02-13       Impact factor: 4.123

10.  Prevalence of CADASIL and Fabry Disease in a Cohort of MRI Defined Younger Onset Lacunar Stroke.

Authors:  Laura L Kilarski; Loes C A Rutten-Jacobs; Steve Bevan; Rob Baker; Ahamad Hassan; Derralynn A Hughes; Hugh S Markus
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.